Heparin/low-molecular-weight-heparins

2021 ◽  
Vol 1885 (1) ◽  
pp. 237-237

1993 ◽  
Vol 13 (S 01) ◽  
pp. S5-S11 ◽  
Author(s):  
Debra Hoppensteadt ◽  
Jeanine Walenga ◽  
A Ahsan ◽  
O Iqbal ◽  
W Jeske ◽  
...  

SummaryThe introduction of low molecular weight heparins has added a new dimension to the pharmacological management of thrombotic disorders. Because of different chemical and pharmacological characteristics, due to the manufacturing process, each LMWH should be considered as a distinct entitity and only be used for its given indication. A list of commercially available LMWHs is included. The mechanism of action of the LMWHs and their use in various disorders are discussed. Available laboratory tests for monitoring LMWHs are presented and their limitations pointed out.



2019 ◽  
Author(s):  
T. Helmecke ◽  
D. Hahn ◽  
M.F. Maitz ◽  
C. Werner




2014 ◽  
Vol 12 (6) ◽  
pp. 893-902 ◽  
Author(s):  
Grigoris Gerotziafas ◽  
Vassiliki Galea ◽  
Elisabeth Mbemba ◽  
Mouna Sassi ◽  
Marie-Paule Roman ◽  
...  






Sign in / Sign up

Export Citation Format

Share Document